CNS Pharmaceuticals Inc — Quarterly Financial Statistics (NASDAQ:CNSP) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics

Quarterly Annual

Cash from operating activities -5.47 M-3.24 M-5.34 M-2.17 M-3.05 M -13.81 M Cash from investing activities -4 188———— — Cash from financing activities 4.96 M9.83 M4.43 M-91.62 K406.87 K 14.57 M Free cash flow -5.48 M-3.24 M-5.34 M-2.17 M-3.05 M -13.81 M

Nouvelles

CNS Pharmaceuticals se recentre sur des actifs en neurologie et oncologie

CNS Pharmaceuticals shifts focus to neurology, oncology assets

CNS Pharmaceuticals nomme Lynne Kelley directrice médicale

CNS Pharmaceuticals names Lynne Kelley as chief medical officer

CNS Pharmaceuticals appoints three new executives to leadership team

CNS Pharmaceuticals’ new CEO outlines strategic overhaul

Corero Network Security nomme Michelle Ragusa-McBain au poste de directrice des canaux

Corero Network Security annonce des améliorations de sa plateforme de protection DDoS

Corero Network Security reports DDoS protection platform enhancements

L’action de CNS Pharmaceuticals chute après le départ du PDG

CNS Pharmaceuticals stock falls after CEO steps down

CNS Pharmaceuticals appoints Rami Levin as new CEO, replacing Climaco